What is the diagnosis and treatment approach for a patient presenting with keratitis, considering their medical history and potential for infectious or fungal causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Treatment of Keratitis

Immediate Diagnostic Approach

For suspected bacterial keratitis, begin empiric broad-spectrum antibiotic therapy immediately while simultaneously obtaining corneal cultures if the infiltrate is central, large (≥2mm), or associated with significant stromal involvement. 1, 2

Critical History Elements

  • Contact lens details: wearing schedule, overnight wear, lens type, hygiene protocol, tap-water exposure, swimming/hot tub use while wearing lenses 1, 2
  • Symptom characteristics: severity of pain, redness, discharge, photophobia, blurred vision, and exact duration 1, 2
  • Risk factors: previous keratitis, HSV/VZV history, trauma, dry eye, recent ocular surgery (including refractive procedures), immunosuppression, diabetes, rosacea, MRSA history 1, 2
  • Medication history: current/recent topical and systemic medications, allergies 1

Essential Physical Examination Findings

Slit-lamp biomicroscopy is mandatory and should specifically document:

  • Infiltrate characteristics: location (central vs peripheral), size in millimeters, depth (superficial vs mid-stromal vs deep), margin definition (bacterial typically shows indistinct/feathery edges), density 1, 3
  • Epithelial defect: presence, size, and shape using fluorescein staining 1, 3
  • Surrounding stromal changes: edema, white cell infiltration, thinning, melting, neovascularization 1, 3
  • Anterior chamber reaction: cell and flare, hypopyon (usually sterile in bacterial keratitis), fibrin 1, 3
  • Eyelid assessment: lagophthalmos, trichiasis, meibomian gland dysfunction, blepharitis 1
  • Facial examination: rosacea, herpes zoster 1, 2

When to Obtain Cultures and Smears

Cultures are NOT needed for most community-acquired cases that respond to empiric therapy. 1, 2

Mandatory culture indications:

  • Central infiltrate or infiltrate ≥2mm 1, 2, 3
  • Significant stromal involvement or corneal melting 1, 2
  • Chronic or unresponsive to broad-spectrum antibiotics 1, 2
  • History of corneal surgery 1, 2
  • Atypical features suggesting fungal, amoebic, or mycobacterial infection 1, 2
  • Multiple infiltrate locations 1

Culture technique:

  • Obtain before initiating antibiotics when possible 1
  • Use heat-sterilized platinum spatula, blade, or jeweler's forceps under slit-lamp magnification 1
  • Scrape advancing borders of infected area, not just purulent material 1
  • Inoculate directly onto culture media at bedside for maximum yield 1, 4
  • Obtain Gram stain and Giemsa stain 1
  • For suspected fungal: add Calcofluor-KOH stain (most sensitive), potassium hydroxide preparation 4

Treatment Algorithm

Bacterial Keratitis (Most Common)

First-line empiric therapy: Fortified vancomycin + fortified tobramycin 5

  • This combination covers the most common Gram-positive (Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa) organisms 5
  • Bacteria account for 83.4% of positive cultures 5
  • Initiate immediately for sight-threatening cases while awaiting culture results 1, 6

Treatment goals:

  • Eradicate microorganisms from corneal tissues 1
  • Reduce pain and discharge 1
  • Resolve corneal and anterior chamber inflammation 1
  • Minimize stromal infiltration, tissue loss, and scarring 1
  • Heal epithelial defect and restore corneal integrity 1
  • Optimize visual function 1

Fungal Keratitis

Suspect fungal etiology when infiltrate shows feathery, finger-like projections with indistinct elevated margins—this appearance is pathognomonic. 4

However, clinical appearance alone is insufficient: cornea specialists correctly differentiate bacterial from fungal keratitis in less than 70% of cases based on appearance. 1, 4

Treatment for fungal keratitis:

  • Natamycin 5% ophthalmic suspension is the FDA-approved first-line agent 7
  • Initial dosing: one drop hourly or every 2 hours 7
  • After 3-4 days, reduce to 6-8 times daily 7
  • Continue for 14-21 days or until resolution 7
  • Indicated for Fusarium solani keratitis, fungal blepharitis, and conjunctivitis 7

Diagnostic confirmation:

  • Calcofluor-KOH stain is most sensitive for fungal elements 4
  • Confocal microscopy shows high sensitivity (66-74% for fungal, 80-100% for Acanthamoeba) and specificity (78-100% for fungal, 84-100% for Acanthamoeba) 8
  • Most common filamentous fungi: Fusarium, Aspergillus, Dematiaceous fungi 4

Viral Keratitis

Herpesviruses are the predominant cause of viral keratitis and a leading cause of corneal opacity. 9

  • Diagnosis requires recognition of characteristic dendritic or geographic epithelial defects 9
  • Immunosuppressed patients display recurring disease with pronounced severity 9
  • Early diagnosis is beneficial for disease management and treatment response 9

Critical Pitfalls to Avoid

  • Never perform aqueous or vitreous taps for hypopyon in bacterial keratitis unless there is high suspicion of endophthalmitis (post-surgery, perforating trauma, sepsis)—hypopyon is usually sterile 1, 2
  • Do not empirically use corticosteroids before ruling out fungal infection, as this worsens fungal keratitis outcomes 4
  • Distinguish epithelial staining from pooling of stain in areas of corneal thinning by wicking away with cotton swab 2
  • Avoid tetracaine for anesthesia before cultures due to antimicrobial effects; avoid preservative-containing anesthetics 1
  • Do not delay treatment while awaiting culture results in sight-threatening cases 1, 6, 10
  • Recognize that highly virulent organisms (Pseudomonas, Streptococcus pneumoniae, Neisseria gonorrhoeae) cause rapid tissue destruction requiring urgent intervention 1
  • Consider polymicrobial infection in patients with multiple systemic risk factors 1

Emerging Diagnostic and Treatment Modalities

  • Confocal microscopy aids in vivo identification of fungal and Acanthamoeba keratitis with high sensitivity and specificity 4, 8
  • PCR and metagenomic deep sequencing are promising but cannot distinguish viable organisms from antigenic material 4, 5
  • PACK-CXL (photoactivated chromophore corneal collagen cross-linking) may benefit patients with corneal melting 5
  • Rose Bengal photodynamic antimicrobial therapy (RB-PDAT) shows promise for fungal keratitis 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for Microbial Keratitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Documenting Corneal Keratitis Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fungal Keratitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Infectious Keratitis Management: 10-Year Update.

Journal of clinical medicine, 2025

Research

Treatment-Resistant Bacterial Keratitis: Challenges and Solutions.

Clinical ophthalmology (Auckland, N.Z.), 2020

Research

Updates in Diagnostic Imaging for Infectious Keratitis: A Review.

Diagnostics (Basel, Switzerland), 2023

Research

Pathobiology and treatment of viral keratitis.

Experimental eye research, 2021

Research

Management of microbial keratitis in general practice.

Australian journal of general practice, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.